BRCA2 and neoplasm: Tumour progression was observed in all monotherapy-treated mice (Fig. 6c, Supplementary Data 1, Supplementary Fig. 8c–f, Supplementary Data 2 and Supplementary Table 6), even in S5-GODL tumours that harbour a BRCA2 mutation48.